NSE · BSE · Real-time

Breaking Corporate Events, Analysed in Real Time

High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.

All New Order Fund Raise Expansion Earning Call Regulatory Approval Production Started Product Launched
Tagged Earning Call
Godrej Properties Reports Record FY26 Bookings of ₹34,171 Cr; Targets ₹39,000 Cr in FY27
Earning Call

Godrej Properties Reports Record FY26 Bookings of ₹34,171 Cr; Targets ₹39,000 Cr in FY27

Godrej Properties Ltd achieved its best-ever annual performance in FY26, surpassing its booking guidance by 26.5% to reach ₹34,171 crore. The company reported a 32% year-on-year increase in net profit and has significantly raised its growth targets for the upcoming fiscal year.

Godrej Properties Ltd
6 May 2026 4 min read
Punjab & Sind Bank Reports Record ₹1,322 Cr Net Profit; Advances Surge 18% in FY26
Earning Call

Punjab & Sind Bank Reports Record ₹1,322 Cr Net Profit; Advances Surge 18% in FY26

Punjab & Sind Bank reached a historic milestone by reporting its highest-ever annual net profit of ₹1,322 crore for FY26. The bank demonstrated robust credit growth across retail and MSME segments while outlining a clear roadmap to reach a ₹4 Lakh crore business by FY29.

Punjab & Sind Bank
6 May 2026 5 min read
Sona Comstar Q4 Revenue Jumps 47% to ₹1,272 Cr Driven by Strong EV Momentum
Earning Call

Sona Comstar Q4 Revenue Jumps 47% to ₹1,272 Cr Driven by Strong EV Momentum

Sona BLW Precision Forgings Limited delivered its best-ever quarterly performance in Q4 FY26, characterized by a 47% surge in revenue and a significant expansion of its order book. The company is successfully diversifying into the railway sector while maintaining its leadership in the global electric vehicle component market.

Sona BLW Precision Forgings Limited
6 May 2026 5 min read
Emcure Pharmaceuticals Achieves ₹9,204 Cr Revenue Milestone; Targets Margin Growth in FY27
Earning Call

Emcure Pharmaceuticals Achieves ₹9,204 Cr Revenue Milestone; Targets Margin Growth in FY27

Emcure Pharmaceuticals surpassed the $1 billion revenue milestone in FY26, driven by a 22.2% surge in international markets. While domestic restructuring led to a temporary Q4 slowdown in the Zuventus portfolio, management has guided for margin expansion and steady growth for FY27.

Emcure Pharmaceuticals Ltd (544210)
5 May 2026 5 min read